Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment

Javitt, D. C. (2023). Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annual Review of Pharmacology and Toxicology, 63(1), 119–141. https://doi.org/10.1146/annurev-pharmtox-051921-093250
Authors:
Daniel C Javitt
Affiliated Authors:
Daniel C Javitt
Columbia Affiliation:
Subjects:
Schizophrenia (MeSH)
Cognitive Dysfunction (MeSH)
Author Keywords:
nmda receptor
cognition
dopamine
glutamate
mismatch negativity
schizophrenia
elink
Publication Type:
Article
Unique ID:
10.1146/annurev-pharmtox-051921-093250
PMID:
36151052
DOI:
10.1146/annurev-pharmtox-051921-093250
Journal:
Annual Review of Pharmacology and Toxicology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: